UFP Technologies, Inc. (UFPT) Operating Margin
- Operating margin · 12 months: Value 15.25%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 15.25% | Operating income / revenue. Period ending 2026-06-30. $96.35M ÷ $631.64M × 100 ≈ 15.25% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 96.35M USD | Operating Income (Loss) |
| Revenue | 631.64M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 451.64M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 83.81M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96.35M | $631.64M | $451.64M | (m) | $83.81M | 15.25% |
| 2026-03-31 | $92.58M | $608.85M | $436.23M | (m) | $79.73M | 15.21% |
| 2025-12-31 | $92.34M | $602.80M | $432.39M | $8.60M | $77.44M | 15.32% |
| 2025-09-30 | $93.09M | (m) | $427.45M | (m) | $75.09M | (m) |
| 2025-06-30 | $94.48M | (m) | $419.29M | (m) | $71.81M | (m) |
| 2025-03-31 | $88.10M | (m) | $388.80M | (m) | $67.03M | (m) |
| 2024-12-31 | $80.90M | (m) | $357.73M | $10.40M | $62.22M | (m) |
| 2024-09-30 | $71.38M | (m) | $331.08M | (m) | $56.72M | (m) |
| 2024-06-30 | $61.66M | (m) | $300.48M | (m) | $53.40M | (m) |
| 2024-03-31 | $60.75M | (m) | $293.72M | (m) | $51.80M | (m) |
| 2023-12-31 | $57.66M | (m) | $287.85M | $7.20M | $50.89M | (m) |
| 2023-09-30 | $55.80M | (m) | $280.44M | (m) | $49.66M | (m) |
| 2023-06-30 | $66.72M | (m) | $278.85M | (m) | $49.01M | (m) |
| 2023-03-31 | $61.88M | (m) | $278.48M | (m) | $48.79M | (m) |
| 2022-12-31 | $55.40M | (m) | $263.53M | $9.30M | $45.80M | (m) |
| 2022-09-30 | $49.16M | (m) | $238.84M | (m) | $42.05M | (m) |
| 2022-06-30 | $28.27M | (m) | $206.10M | (m) | $37.03M | (m) |
| 2022-03-31 | $22.28M | (m) | $173.32M | (m) | $32.18M | (m) |
| 2021-12-31 | $21.22M | (m) | $155.21M | $8.50M | $29.48M | (m) |
| 2021-09-30 | $21.52M | (m) | $145.71M | (m) | $27.63M | (m) |
| 2021-06-30 | $20.17M | (m) | $139.77M | (m) | $27.61M | (m) |
| 2021-03-31 | $16.96M | (m) | $135.22M | (m) | $27.05M | (m) |
| 2020-12-31 | $16.73M | (m) | $134.69M | $8.20M | $27.49M | (m) |
| 2020-09-30 | $18.54M | (m) | $137.41M | (m) | $28.23M | (m) |
| 2020-06-30 | $20.95M | (m) | $140.71M | (m) | $28.63M | (m) |
| 2020-03-31 | $24.53M | (m) | $145.04M | (m) | $29.76M | (m) |
| 2019-12-31 | $24.71M | (m) | $144.42M | $9.50M | $29.25M | (m) |
| 2019-09-30 | $23.46M | (m) | $145.92M | (m) | $29.43M | (m) |
| 2019-06-30 | $23.20M | (m) | $145.23M | (m) | $28.79M | (m) |
| 2019-03-31 | $22.30M | (m) | $144.23M | (m) | $28.41M | (m) |
| 2018-12-31 | $19.61M | (m) | $142.15M | (m) | $27.76M | (m) |
| 2018-09-30 | $16.18M | (m) | (m) | (m) | $26.32M | (m) |
| 2018-06-30 | $12.79M | (m) | (m) | (m) | $25.48M | (m) |
| 2018-03-31 | $11.05M | (m) | (m) | (m) | $24.12M | (m) |
| 2017-12-31 | $11.69M | $147.84M | (m) | $1.10M | $23.84M | 7.91% |
| 2017-09-30 | $11.89M | $147.13M | (m) | (m) | $23.77M | 8.08% |
| 2017-06-30 | $13.48M | $148.66M | (m) | (m) | $24.11M | 9.06% |
| 2017-03-31 | $13.74M | $148.68M | (m) | (m) | $24.52M | 9.24% |
| 2016-12-31 | $12.24M | $146.13M | (m) | $1.30M | $24.11M | 8.37% |
| 2016-09-30 | $12.58M | $143.56M | (m) | (m) | $24.01M | 8.76% |
| 2016-06-30 | $11.56M | $140.78M | (m) | (m) | $23.58M | 8.21% |
| 2016-03-31 | $10.85M | $139.38M | (m) | (m) | $23.89M | 7.79% |
| 2015-12-31 | $11.71M | $138.85M | (m) | $1.40M | $24.01M | 8.44% |
| 2015-09-30 | $11.59M | $140.18M | (m) | (m) | $23.88M | 8.27% |
| 2015-06-30 | $11.63M | $141.15M | (m) | (m) | $24.22M | 8.24% |
| 2015-03-31 | $10.93M | $138.68M | (m) | (m) | $23.98M | 7.88% |
| 2014-12-31 | $11.56M | $139.31M | (m) | $1.20M | $23.85M | 8.30% |
| 2014-09-30 | $14.40M | $139.03M | (m) | (m) | $23.70M | 10.36% |
| 2014-06-30 | $15.79M | $138.33M | (m) | (m) | $23.51M | 11.42% |
| 2014-03-31 | $17.64M | $140.13M | (m) | (m) | $23.13M | 12.59% |
| 2013-12-31 | $17.40M | $139.22M | (m) | $1.20M | $23.24M | 12.50% |
| 2013-09-30 | $16.67M | $137.60M | (m) | (m) | $23.16M | 12.12% |
| 2013-06-30 | $16.26M | $134.87M | (m) | (m) | $22.64M | 12.06% |
| 2013-03-31 | $15.93M | $132.71M | (m) | (m) | $21.96M | 12.01% |
| 2012-12-31 | $16.67M | $130.96M | (m) | $1.30M | $21.53M | 12.73% |
| 2012-09-30 | $16.29M | $129.07M | (m) | (m) | $20.80M | 12.62% |
| 2012-06-30 | $15.48M | $127.86M | (m) | (m) | $20.86M | 12.11% |
| 2012-03-31 | $15.49M | $127.69M | (m) | (m) | $21.16M | 12.13% |
| 2011-12-31 | $15.72M | $127.24M | (m) | (m) | $21.37M | 12.35% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $14.39M | $120.77M | (m) | (m) | $20.24M | 11.92% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $8.19M | $99.23M | (m) | (m) | $18.54M | 8.26% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |